Suchergebnisse - "Feng, Cheng"

PubPharm (12)

1

Hypoxic-Ischemic Brain Injury in ECMO : Pathophysiology, Neuromonitoring, and Therapeutic Opportunities

enthalten in: Cells | 2023

von Khanduja, S. | Kim, J. | Kang, J. | +5

2

NSC828779 Alleviates Renal Tubulointerstitial Lesions Involving Interleukin-36 Signaling in Mice

enthalten in: Cells | 2021

von Yang, S. | Hung, S. | Chu, L. | +12

3

Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration

enthalten in: Cells | 2021

von Lawal, B. | Kuo, Y. | Tang, S. | +4

4

Inhibition of FABP6 Reduces Tumor Cell Invasion and Angiogenesis through the Decrease in MMP-2 and VEGF in Human Glioblastoma Cells

enthalten in: Cells | 2021

von Pai, F. | Huang, H. | Tsai, Y. | +4

5

Interleukin-26 Has Synergistic Catabolic Effects with Palmitate in Human Articular Chondrocytes via the TLR4-ERK1/2-c-Jun Signaling Pathway

enthalten in: Cells | 2021

von Chen, Y. | Wang, C. | Cheng, C. | +4

6

Interleukin-26 Has Synergistic Catabolic Effects with Palmitate in Human Articular Chondrocytes via the TLR4-ERK1/2-c-Jun Signaling Pathway

in: Cells | 2021

von Yi-Ting Chen | Chih-Chien Wang | Chia-Pi Cheng | +4

7

Activating Transcription Factor 3 Protects against Restraint Stress-Induced Gastrointestinal Injury in Mice

in: Cells | 2021

von Dun-Jie Chuang | Subhashree Pethaperumal | Bijaya Siwakoti | +6

8

Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration

in: Cells | 2021

von Bashir Lawal | Yu-Cheng Kuo | Sung-Ling Tang | +4

9

NSC828779 Alleviates Renal Tubulointerstitial Lesions Involving Interleukin-36 Signaling in Mice

in: Cells | 2021

von Shin-Ruen Yang | Szu-Chun Hung | Lichieh Julie Chu | +12

10

NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer

enthalten in: Cells | 2020

von Huang, T. | Chang, T. | Chin, Y. | +18